Aardvark Therapeutics, Inc.
SEC CIK 1774857 · AARD · last insider filing 2026-02-11
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Lee Tien-Li | Director · Chief Executive Officer | filed 2025 - 2026 |
| Graf Susan E | Director | filed 2025 - 2025 |
| Baynes Roy D. | Director | filed 2025 - 2025 |
| Chi Jeffrey | Director | filed 2025 - 2025 |
| Tong Victor Edward Jr | Director | filed 2025 - 2025 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Sun Nelson | Chief Financial Officer | filed 2025 - 2026 |
| Jaiman Manasi | Chief Medical Officer | filed 2025 - 2026 |
| Jones Bryan | Chief Operating Officer | filed 2025 - 2025 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.